NSEChange in Director(s)1d ago · 23 Jul 2026, 09:18 pm
Change in Director(s)
Dr. Reddy's Laboratories Limited · DRREDDY
✦ AI SummaryMgmt Change
Dr. Reddy's Laboratories Limited has informed the Exchange regarding the re-appointment of Dr. K P Krishnan as an Independent Director and the appointment of Mr. Srikanth Velamakanni as an Independent Director, and the appointment of M/s Deloitte Haskins & Sells, LLP as Statutory Auditors.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.
Attachments (1)
📄pdf
Download →
DRREDDY_23072026211751_SEintimation_Regulation_30_Director_and_Stat_Auditor_signed.pdf
View document text
Dr. Reddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills
Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900
Fax: + 91 40 4900 2999
Email: mail@drreddys.com
Web: www.drreddys.com
July 23, 2026
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited. (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (‘SEBI Listing Regulations Regulations’)
Dear Sir/Madam,
Pursuant to Regulation 30 of the SEBI Listing Regulations and in furtherance to our intimation dated
May 12, 2026, we hereby inform that, the members of the Company at the 42nd Annual General Meeting
(‘AGM’) held today, have approved the following resolutions with requisite majority:
1. Re-appointment of Dr. K P Krishnan (DIN: 01099097) as an Independent Director
Approved re-appointment of Dr. K P Krishnan (DIN: 01099097) as an Independent Director for a
second term of five consecutive years from January 7, 2027 to January 6, 2032, not liable to retire by
rotation.
Dr. Krishnan is not related to any of the Directors or Key Managerial Personnel of the Company and
is not debarred from holding the office of Director by virtue of any SEBI order or any other such
authority. He meets the criteria for being re-appointed as an Independent Director under the applicable
laws.
2. Appointment of Mr. Srikanth Velamakanni (DIN: 01722758) as an Independent Director
Approved appointment of Mr. Srikanth Velamakanni (DIN: 01722758) as an Independent Director, for
a term of five consecutive years, from July 1, 2026 to June 30, 2031, not liable to retire by rotation.
Mr. Srikanth is not related to any of the Directors or Key Managerial Personnel of the Company and is
not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.
He meets the criteria for being appointed as an Independent Director under the applicable laws.
3. Appointment of M/s Deloitte Haskins & Sells, LLP, Chartered Accountants as Statutory Auditors
Approved appointment of M/s Deloitte Haskins & Sells, LLP, Chartered Accountants (Firm
Registration No. 117366W/W-100018), as the Statutory Auditors of the Company, for a term of five
consecutive years, commencing from the conclusion of the 42nd AGM till the conclusion of the 47th
AGM.
The disclosures required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master
Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are attached as
Annexures.
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR
Encl: as above
Details of Dr. K P Krishnan (DIN: 01099097)
Sl.no. Particulars Details
1. Reason for change viz. appointment, Re-appointment
re-appointment, resignation, removal,
death or otherwise
2. Date of appointment/re- Re-appointment of Dr. K P Krishnan (DIN:
appointment/cessation (as applicable) 01099097) as an Independent Director of the
& term of appointment/re- Company for a second term of five consecutive
appointment years from January 7, 2027 to January 6, 2032, not
liable to retire by rotation.
3. Disclosure of relationships between Dr. K P Krishnan is not related to any of the
directors (in case of appointment of a Directors of the Company
director)
Brief Profile of Dr. Krishnan:
Dr. K.P. Krishnan is a former IAS officer with 37 years of distinguished service in public policy, economic
governance, and regulatory reform across the Government of India, Government of Karnataka, and the
World Bank. He has held key national leadership roles, including Secretary, Ministry of Skill Development
and Entrepreneurship; Additional/Special Secretary in the Ministries of Finance and Rural Development;
and Secretary to the Prime Minister’s Economic Advisory Council.
A respected academician, he has taught at IIM Bangalore, ISB, and Ashoka University, held the Bok
Visiting Professorship at the University of Pennsylvania Law School, and served as IEPF Chair Professor
at NCAER, New Delhi. He is currently a Distinguished Fellow at the Isaac Centre for Public Policy, Ashoka
University.
Dr. Krishnan serves on the boards and advisory councils of several leading corporates and non-profits,
including Dr. Reddy’s Laboratories, Tata Consumer Products, Shriram Capital, ASREC India, Helios
Trustee, Razorpay, and the Sanmar Group. He holds degrees in Economics (St. Stephen’s College), Law
(Campus Law Centre, University of Delhi), and a Ph.D. in Economics (IIM Bangalore).
Details of Mr. Srikanth Velamakanni (DIN: 01722758)
Sl.no. Particulars Details
1. Reason for change viz. appointment, Appointment
re-appointment, resignation, removal,
death or otherwise
2. Date of appointment/re- Appointment of Mr. Srikanth Velamakanni (DIN:
appointment/cessation (as applicable) 01722758) as an Independent Director for a term
& term of appointment/re- of five consecutive years, effective from July 1,
appointment 2026 to June 30, 2031.
3. Disclosure of relationships between Mr. Srikanth Velamakanni is not related to any of
directors (in case of appointment of a the Directors of the Company
director)
Brief Profile: Mr. Srikanth Velamakanni
Mr. Srikanth Velamakanni is one of India’s most influential technology leaders and a global champion of
artificial intelligence. He is the Co-Founder and Group Chief Executive of Fractal, India’s first publicly
listed pure-play AI company. He also serves as the Chairperson of Nasscom and as a Founder-Trustee of
Plaksha University. Srikanth's work is guided by a long-term commitment to building technology that
expands human potential.
Details of Statutory Auditors
Sl.no. Particulars Details
1. reason for change viz. Appointment
appointment, re-
appointment, resignation,
removal, death or
otherwise
2. Date of appointment/re- Appointment of M/s Deloitte Haskins & Sells, LLP, Chartered
appointment/cessation (as Accountants (Firm Registration No. 117366W/W-100018), as the
applicable) & term of Statutory Auditors of the Company, for a term of five consecutive years,
appointment/re- commencing from the conclusion of the 42nd Annual General Meeting
appointment (AGM) till the conclusion of the 47th AGM.
3. Brief profile (in case of Deloitte Haskins & Sells, Mumbai was constituted in 1997 and has been
appointment) converted to a Limited Liability Partnership (LLP), with the name
Deloitte Haskins & Sells LLP ("“DHS LLP”" or "“Firm"”), w.e.f.
November 20, 2013. DHS LLP is registered with the Institute of
Chartered Accountants of India (Registration No. 117366W/W-100018)
and is a part of Deloitte Haskins & Sells & Affiliates being the Network
of Firms registered with the ICAI. The registered office of the Firm is
One International Center, Tower 3, 31st Floor, Senapati Bapat Marg,
Elphinstone Road (West), Mumbai - 400013, Maharashtra, India.
4. Disclosure of relationships Not applicable
between directors (in case
of appointment of a
director)